Navigation Links
Ranbaxy In-Licences NDDS Analgesic Molecule From Ethypharm

Ranbaxy Laboratories Limited today entered into an in-licensing agreement with Ethypharm S.A., France for novel drug delivery system (NDDS) analgesic // , Tramadol in the Indian market The agreement was signed with Ethypharm LL India (Ethypharm), the wholly-owned subsidiary of the French drug major for 50 mg strength, the company said in a statement.

The product will be supplied from Ethypharm's manufacturing facility near Mumbai and marketed and distributed by Ranbaxy under its brand name 'Trambax', it added.

Commenting on the agreement Ranbaxy India and Middle East Regional Director Sanjeev I Dani, said, the introduction of Trambax tablets will further strengthen thecompany's portfolio in the pain management segment.

'The Indian market of Tramadol is approximately Rs 15 crores annually and is expected to grow significantly with the addition of this Novel Drug Delivery System, making the administration of the product easier and more convenient to the patient,' Ethypharm LL India Chief Executive Officer Ajey Kumar said.

Curently, Ranbaxy has a basket of 30 novel products already on pharmacy shelves in the NDDS space in India. With the introduction of the NDDS product Trambax, Ranbaxy has so far launched 2 in-licenced products and has 5 more such products in the pipeline, for launch during the year, it added.

Tramadol is used for treatment of severe to moderate pain in trauma cases and is also used as an adjunct therapy in the treatment of cancer patients.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ranbaxy Licences NDDS Analgesic Molecule From Ethypharm

(Date:11/18/2014)... By Dennis Thompson ... (HealthDay News) -- An experimental antibody drug could prove ... who have side effects with cholesterol-lowering statin medications. ... at the American Heart Association annual meeting in Chicago. ... is currently the most widely used alternative to statins, ...
(Date:11/18/2014)... Nov. 18, 2014 (HealthDay News) -- Cocaine users can ... hard to detect, which can put them at increased ... warns. Researchers in Chicago compared heart imaging test ... didn,t use the illegal drug. Those using cocaine ... smallest blood vessels, which were considered significant when compared ...
(Date:11/18/2014)... Recently, BellasDress has announced the launch of 85 ... and using comfortable fabrics, the new styles of prom dresses ... of wonderful holiday gifts in a variety of colors and ... dresses, and they are created by top designers,” said the ... great addition to our sales team and more than one ...
(Date:11/18/2014)... 2014 Global Partnership for ... telehealth platform to bring quality healthcare to populations ... GPT created Global Partnership for TeleHealth Missions (GPTM), ... telehealth network. GPTM focuses specifically on medical ... disaster relief organizations. , Michael D’Ambrosio, ...
(Date:11/18/2014)... Altec Products, Inc., a leader in enterprise ... sponsorship of the 2014 Great Plains User Conference (GPUC) ... the Fargo, ND Microsoft Campus. GPUC is an annual ... sessions and structured networking opportunities. , The two-day ... for users to learn how to extend the power ...
Breaking Medicine News(10 mins):Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Cocaine Can Cause Heart Problems: Study 2Health News:85 New Models Of White Prom Dresses From BellasDress.com Online For Sale 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:Altec Joins the 2014 Great Plains User Conference (GPUC) as a Gold Sponsor, Demonstrating the Capabilities of Certified for Microsoft Dynamics Product doc-link 2Health News:Altec Joins the 2014 Great Plains User Conference (GPUC) as a Gold Sponsor, Demonstrating the Capabilities of Certified for Microsoft Dynamics Product doc-link 3
... Bag(TM) Events Bring Educational Outreach to Senior Centers, ... TAMPA, Fla., July 10 Eight out of ten older ... high blood pressure or diabetes. According to CVS/pharmacy, fifty percent ... or more prescriptions regularly. With increased use of medications, both ...
... Connectyx Technologies Holdings Group, Inc. (Other OTC: CTYX) is pleased ... as the market leader in the Electronic Personal Health Record ... yesterday,s Nationwide Teleconference. Mr. Schuman went on to state ... members by the end of 2011 through continually expanding its ...
... The Quigley Corporation, (Nasdaq: QGLY ) , ... announced that Dr. Richard Rosenbloom has resumed providing services to the ... from the Company in late May, 2009. , , Ted ... pleased to have Dr. Rosenbloom again serving our Pharma subsidiary and ...
... ... Not only does the company take great pride in their surgical instruments, Spectrum focuses on ... ... that on June 17, 2009, for the 2nd consecutive year, the company was recipient of ...
... ... Allegheny General Hospital. , ... July 9, 2009 -- A Washington County woman is recovering well today after undergoing a ... of Canonsburg, is one of just a handful of bariatric patients in the region to ...
... , SOLON, Ohio , July 9 Nestle USA,s ... with the Food and Drug Administration (FDA) and the Centers ... E. coli O157:H7 illnesses associated with the consumption of raw, ... evidence of E. coli O157:H7 in a retained production sample ...
Cached Medicine News:Health News:The National Council on Aging and CVS/pharmacy Educate Tampa Seniors on Medication Management and How to Save Money on Prescription Drugs 2Health News:The National Council on Aging and CVS/pharmacy Educate Tampa Seniors on Medication Management and How to Save Money on Prescription Drugs 3Health News:The National Council on Aging and CVS/pharmacy Educate Tampa Seniors on Medication Management and How to Save Money on Prescription Drugs 4Health News:Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 2Health News:Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference 3Health News:Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary 2Health News:Dr. Richard Rosenbloom Resumes Services To The Quigley Corporation's Pharma Subsidiary 3Health News:Spectrum Surgical Instruments Receives 2009 World Class Customer Service Award 2Health News:Canonsburg Woman Undergoes Robot-Assisted Weight Loss Procedure at AGH 2Health News:Canonsburg Woman Undergoes Robot-Assisted Weight Loss Procedure at AGH 3Health News:Canonsburg Woman Undergoes Robot-Assisted Weight Loss Procedure at AGH 4Health News:Nestle(R) TOLL HOUSE(R) Refrigerated Cookie Dough Recall Update - July 9, 2009 2
(Date:11/18/2014)... November 18, 2014 This report ... the overall new requirements of application dossiers for medical ... but also provides the guidance of practical operation ... products entry into the Chinese medical device market. ... market is one of segment market of the most ...
(Date:11/18/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... December 8, 2014 at 9:00 a.m. Eastern Time to discuss ... American Society of Hematology Annual Meeting and Exposition.  ... dialing 877-443-5662 or access the webcast at www.isispharm.com .  ... at the same address. ABOUT ISIS PHARMACEUTICALS, ...
(Date:11/18/2014)... Tocagen Inc. today announced that interim data ... at six months for recurrent high grade glioma (HGG) ... to published benchmarks. HGG includes glioblastoma, the most common ... were delivered in an oral presentation at the 19 th ... Society for Neuro-Oncology (SNO) by Tim Cloughesy , ...
Breaking Medicine Technology:Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 2Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 3Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 4Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 6Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 7Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 8Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 2Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 4Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 5
... SILVER SPRING, Md., May 6, 2011 The U.S. Food ... allow a new group of patients at risk of stroke ... RX Acculink carotid stent. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... neck bring blood to the brain. The blood flow in ...
... BEACH, Calif., May 6, 2011 Yesterday, the ... Novartis drug Afinitor® (everolimus) for the treatment of ... less than five percent of all pancreatic cancer ... aggressive than the more common form of pancreatic ...
Cached Medicine Technology:FDA Expands Approved Use For Carotid Stent 2FDA Expands Approved Use For Carotid Stent 3FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors 2
... Dehydroepiandrosterone sulfate (DHEA-S) is the sulfate ester ... by enzymatic conversion of DHEA in adrenal ... C19 steroid secreted by the adrenal cortex, ... estrogen biosynthesis. DHEA possesses relatively weak androgenic ...
... sulfate (DHEA-S) is the sulfate ester of ... enzymatic conversion of DHEA in adrenal and ... steroid secreted by the adrenal cortex, and ... biosynthesis. DHEA possesses relatively weak androgenic activity, ...
Inquire...
... It is a compact Latex based reagent kit ... well as to determine the level of RF ... patient sera. The kit includes antigen coated fine ... control sera in plastic squeezable dropping bottles, re-usable ...
Medicine Products: